US Stock MarketDetailed Quotes

BNOX Bionomics

Watchlist
  • 0.302
  • +0.015+5.29%
Close Dec 12 16:00 ET
5.90MMarket Cap-0.24P/E (TTM)

Bionomics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-0.07%-4.43M
-0.29%-14.68M
-4.43M
2.19%-14.64M
-164.22%-14.97M
Net income from continuing operations
85.29%-804.79K
27.54%-15.49M
----
---5.47M
-42.84%-21.38M
----
----
----
----
-129.07%-14.97M
Operating gains losses
-4,160.07%-2.73M
34.21%-366.33K
----
--67.32K
-209.34%-556.78K
----
----
----
----
164.75%509.22K
Depreciation and amortization
-0.12%165.71K
-0.03%662.99K
----
--165.91K
-13.10%663.19K
----
----
----
----
-40.28%763.17K
Other non cash items
-30.89%111.08K
-347.96%-1.75M
----
--160.72K
11.05%707.75K
----
----
----
----
134.80%637.34K
Change In working capital
-332.25%-1.2M
-68.27%1.45M
----
--516.08K
218.97%4.58M
----
----
----
----
-414.04%-3.85M
-Change in receivables
167.22%10.92K
-92.77%299.2K
----
---16.25K
203.14%4.14M
----
----
----
----
-363.56%-4.01M
-Change in prepaid assets
-46.72%227.66K
94.69%338.71K
----
--427.32K
--173.98K
----
----
----
----
----
-Change in payables and accrued expense
-830.80%-1.29M
111.27%1.08M
----
--175.87K
-24.01%512.26K
----
----
----
----
1,517.23%674.08K
-Change in other current assets
----
----
----
----
----
----
----
----
----
-541.71%-412.94K
-Change in other current liabilities
45.32%-19.72K
-26.41%-126.11K
----
---36.06K
---99.77K
----
----
----
----
----
-Change in other working capital
-280.01%-132.22K
0.00%-139.17K
----
---34.79K
-34.21%-139.17K
----
----
----
----
43.28%-103.7K
Cash from discontinued investing activities
Operating cash flow
-0.07%-4.43M
-0.29%-14.68M
----
---4.43M
2.19%-14.64M
----
----
----
----
-164.22%-14.97M
Investing cash flow
Cash flow from continuing investing activities
0
-59.34%130.01K
0
809.70%427.68K
Net PPE purchase and sale
----
----
----
----
----
----
--0
----
--0
365.07%119.38K
Net intangibles purchase and sale
----
----
----
----
----
----
--0
----
--0
----
Net business purchase and sale
----
----
----
----
----
----
--0
----
--0
----
Net investment purchase and sale
----
----
----
----
----
----
--0
----
--0
436.69%299.68K
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
----
--0
-59.34%130.01K
--0
809.70%427.68K
Financing cash flow
Cash flow from continuing financing activities
-137.11%-227.34K
291.58%15.11M
70.12%6.93M
2,512.98%612.54K
-79.22%3.86M
13.16K
-107.04%-205.49K
-78.18%4.08M
97.07%-25.39K
-21.67%18.57M
Net issuance payments of debt
----
----
----
----
----
----
-53.12%-26.86K
-4.44%-28.41K
42.94%-25.39K
98.66%-119.85K
Net common stock issuance
--0
162.07%10.11M
-76.15%1.2M
--6.26M
-82.95%3.86M
----
----
-75.69%5.05M
--0
-31.30%22.63M
Cash dividends paid
----
----
----
----
----
----
--0
----
--0
----
Proceeds from stock option exercised by employees
--409
--5M
----
--0
--0
----
--0
----
--0
----
Net other financing activities
95.97%-227.75K
----
--5.01M
---5.65M
----
----
28.47%-178.63K
----
----
-1,160.64%-3.94M
Cash from discontinued financing activities
Financing cash flow
-137.11%-227.34K
291.58%15.11M
70.12%6.93M
2,512.98%612.54K
-79.22%3.86M
--13.16K
-107.04%-205.49K
-78.18%4.08M
97.07%-25.39K
-21.67%18.57M
Net cash flow
Beginning cash position
4.15%12.69M
-47.50%12.18M
-59.86%8.21M
-44.24%12.18M
18.36%23.21M
--15.08M
-31.87%20.62M
28.58%20.46M
6.83%21.85M
470.01%19.61M
Current changes in cash
-22.09%-4.66M
103.97%428.02K
839.42%1.76M
-78.74%-3.82M
-367.32%-10.78M
---3.29M
-3,152.48%-5.54M
-98.61%187.62K
52.79%-2.14M
-77.58%4.03M
Effect of exchange rate changes
190.57%138.37K
131.57%76.97K
86.91%-98.03K
-120.46%-152.77K
55.50%-243.82K
---241.06K
99.91%-671.5376
-117.37%-748.67K
4,623.42%746.58K
-5,477.45%-547.87K
End cash Position
-0.57%8.16M
4.15%12.69M
-51.50%10.13M
-59.86%8.21M
-47.24%12.18M
--12.18M
-49.21%15.08M
-28.60%20.88M
28.58%20.46M
7.83%23.09M
Free cash flow
-0.07%-4.43M
-0.29%-14.68M
-32.32%-5.32M
-109.92%-4.43M
2.20%-14.64M
---3.17M
-95.04%-5.33M
27.26%-4.02M
44.21%-2.11M
-164.19%-14.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -0.07%-4.43M-0.29%-14.68M-4.43M2.19%-14.64M-164.22%-14.97M
Net income from continuing operations 85.29%-804.79K27.54%-15.49M-------5.47M-42.84%-21.38M-----------------129.07%-14.97M
Operating gains losses -4,160.07%-2.73M34.21%-366.33K------67.32K-209.34%-556.78K----------------164.75%509.22K
Depreciation and amortization -0.12%165.71K-0.03%662.99K------165.91K-13.10%663.19K-----------------40.28%763.17K
Other non cash items -30.89%111.08K-347.96%-1.75M------160.72K11.05%707.75K----------------134.80%637.34K
Change In working capital -332.25%-1.2M-68.27%1.45M------516.08K218.97%4.58M-----------------414.04%-3.85M
-Change in receivables 167.22%10.92K-92.77%299.2K-------16.25K203.14%4.14M-----------------363.56%-4.01M
-Change in prepaid assets -46.72%227.66K94.69%338.71K------427.32K--173.98K--------------------
-Change in payables and accrued expense -830.80%-1.29M111.27%1.08M------175.87K-24.01%512.26K----------------1,517.23%674.08K
-Change in other current assets -------------------------------------541.71%-412.94K
-Change in other current liabilities 45.32%-19.72K-26.41%-126.11K-------36.06K---99.77K--------------------
-Change in other working capital -280.01%-132.22K0.00%-139.17K-------34.79K-34.21%-139.17K----------------43.28%-103.7K
Cash from discontinued investing activities
Operating cash flow -0.07%-4.43M-0.29%-14.68M-------4.43M2.19%-14.64M-----------------164.22%-14.97M
Investing cash flow
Cash flow from continuing investing activities 0-59.34%130.01K0809.70%427.68K
Net PPE purchase and sale --------------------------0------0365.07%119.38K
Net intangibles purchase and sale --------------------------0------0----
Net business purchase and sale --------------------------0------0----
Net investment purchase and sale --------------------------0------0436.69%299.68K
Cash from discontinued investing activities
Investing cash flow --------------------------0-59.34%130.01K--0809.70%427.68K
Financing cash flow
Cash flow from continuing financing activities -137.11%-227.34K291.58%15.11M70.12%6.93M2,512.98%612.54K-79.22%3.86M13.16K-107.04%-205.49K-78.18%4.08M97.07%-25.39K-21.67%18.57M
Net issuance payments of debt -------------------------53.12%-26.86K-4.44%-28.41K42.94%-25.39K98.66%-119.85K
Net common stock issuance --0162.07%10.11M-76.15%1.2M--6.26M-82.95%3.86M---------75.69%5.05M--0-31.30%22.63M
Cash dividends paid --------------------------0------0----
Proceeds from stock option exercised by employees --409--5M------0--0------0------0----
Net other financing activities 95.97%-227.75K------5.01M---5.65M--------28.47%-178.63K---------1,160.64%-3.94M
Cash from discontinued financing activities
Financing cash flow -137.11%-227.34K291.58%15.11M70.12%6.93M2,512.98%612.54K-79.22%3.86M--13.16K-107.04%-205.49K-78.18%4.08M97.07%-25.39K-21.67%18.57M
Net cash flow
Beginning cash position 4.15%12.69M-47.50%12.18M-59.86%8.21M-44.24%12.18M18.36%23.21M--15.08M-31.87%20.62M28.58%20.46M6.83%21.85M470.01%19.61M
Current changes in cash -22.09%-4.66M103.97%428.02K839.42%1.76M-78.74%-3.82M-367.32%-10.78M---3.29M-3,152.48%-5.54M-98.61%187.62K52.79%-2.14M-77.58%4.03M
Effect of exchange rate changes 190.57%138.37K131.57%76.97K86.91%-98.03K-120.46%-152.77K55.50%-243.82K---241.06K99.91%-671.5376-117.37%-748.67K4,623.42%746.58K-5,477.45%-547.87K
End cash Position -0.57%8.16M4.15%12.69M-51.50%10.13M-59.86%8.21M-47.24%12.18M--12.18M-49.21%15.08M-28.60%20.88M28.58%20.46M7.83%23.09M
Free cash flow -0.07%-4.43M-0.29%-14.68M-32.32%-5.32M-109.92%-4.43M2.20%-14.64M---3.17M-95.04%-5.33M27.26%-4.02M44.21%-2.11M-164.19%-14.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----Unqualified Opinion--------Unqualified Opinion
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Salesforce
CRM
+0.90%
Apple
AAPL
+0.60%
Microsoft
MSFT
+0.13%
Coinbase
COIN
-0.27%
Meta Platforms
META
-0.30%

Unlock the Full List